The adjusted VE against infection of any severity was 58.8% for BNT162b2 and 73.9% for mRNA-1273. Both vaccines maintained high protection in children with underlying medical conditions and reduced ...

Find the latest covid-19 vaccine news from Fast company. See related business and technology articles, photos, slideshows and ...

The fall-winter COVID-19 vaccine designed to counter XBB, a subvariant of the Omicron strain, is now available nationwide for ...

With articles such as Why Marty Makary Was the Worst FDA Commissioner In 25 Years and Paranoia, Turmoil and Backlash: Inside ...

Japan’s first domestically produced vaccine for the virus that causes COVID-19 has been cleared for regulatory approval.

Will a hantavirus outbreak offset the regulatory risks weighing on Moderna stock? The path to recovery is far from certain.

Big boost to India's fight against Covid-19 as Bharat Biotech's vaccine gets approval from Central Drugs Standard Control Organisation (CDSCO). The UK approved the second 'bivalent' booster for the ...

RSV and flu mRNA vaccines struggle with lower durability, higher side effects, and weak uptake, leading to program cuts and ...

In a comprehensive update on COVID-19 immunization status, the Government of India has released the latest list of COVID-19 ...

While the world has largely moved past the acute phase of the COVID-19 pandemic, the infectious disease landscape in May 2026 is far from quiet. From the emergence of the 'Cicada' variant and a ...

The efficacy of flu shots is not always the same and it’s not always optimal. Some years, they can reduce the risk of illness by as little as 20% to 30%. Messenger RNA technology, or mRNA, is widely ...